(Q38223294)

31 August 2017

title

The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells (English)

1 reference

31 August 2017

Huiying Liu

1

1 reference

31 August 2017

Xiaofeng Zhang

2

1 reference

31 August 2017

Jun Li

3

1 reference

31 August 2017

Bin Sun

4

1 reference

31 August 2017

Haihua Qian

5

1 reference

31 August 2017

Zhengfeng Yin

6

1 reference

31 August 2017

publication date

26 June 2014

1 reference

Journal of Cancer Research and Clinical Oncology

31 August 2017

published in

1 reference

31 August 2017

volume

141

1 reference

31 August 2017

issue

2

1 reference

31 August 2017

page(s)

189-201

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-014-1752-x

31 August 2017

exact match

0 references

cites work

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

The Snail genes as inducers of cell movement and survival: implications in development and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Plasticity of disseminating cancer cells in patients with epithelial malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

A perspective on cancer cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Malignant cells facilitate lung metastasis by bringing their own soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial-mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Circulating tumor cells as a window on metastasis biology in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Tumor cell dissemination: emerging biological insights from animal models and cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

E-cadherin expression in primary carcinomas of the breast and its distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Apoptosis of circulating tumor cells in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Stepping out of the flow: capillary extravasation in cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

A novel platform for detection of CK+ and CK- CTCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

EMT and dissemination precede pancreatic tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Role of cadherins in the transendothelial migration of melanoma cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Development and characterization of gemcitabine-resistant pancreatic tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Visualizing extravasation dynamics of metastatic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Anoikis: an emerging hallmark in health and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial-mesenchymal plasticity in carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Cancer theory faces doubts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1752-X

Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells

21 January 2018

1 reference

12 December 2020

Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation

1 reference

12 December 2020

Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

1 reference

12 December 2020

Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells

1 reference

12 December 2020

Isolated tumour cells in blood and E-cadherin expression in oesophageal squamous cell cancer

1 reference

12 December 2020

Epithelial-mesenchymal transition mediates anoikis resistance and enhances invasion in pleural effusion-derived human lung cancer cells

1 reference

12 December 2020

Genetic heterogeneity and cancer drug resistance

1 reference

12 December 2020

Characterization of circulating tumor cells by fluorescence in situ hybridization

1 reference

12 December 2020

High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis

1 reference

12 December 2020

Overexpression of E-cadherin protein in metastatic breast cancer cells in bone.

1 reference

12 December 2020

Epithelial-to-mesenchymal transition is important to metastasis, but questions remain

1 reference

12 December 2020

Circulating tumor cells and individualized chemotherapy

1 reference

12 December 2020

Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis

1 reference

12 December 2020

Medicine. Cancer's circulation problem

1 reference

12 December 2020

Frequent detection and immunophenotyping of prostate-derived cell clusters in the peripheral blood of prostate cancer patients.

1 reference

12 December 2020

10.1007/S00432-014-1752-X

Identifiers

DOI

1 reference

release_7tfdvh7wcnhrfkc7utjqmvvgoq

31 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7tfdvh7wcnhrfkc7utjqmvvgoq

24 November 2022

mapped directly with Wikidata item

1 reference